XNAS · ALVO
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Alvotech Ordinary Shares

Alvotech Ordinary Shares

$3.61
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ALVO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Alvotech Ordinary Shares
Listed since
2022
Employees
1K
Country
US

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.61
Last session
Day high
$3.61
Last session
Day low
$3.61
Last session
Previous close
$3.61
52W high
$4.33
-16.53% from high
52W low
$3.54
9% of range
Market cap
$1.2B
Shares out
338.2M
VWAP
$3.61
Last session
Price history computed in-house
1W
-3.99%
SMA 50 $3.86 · below
SMA 200 $3.86 · below
52W position 9%
Veridion warehouse edge

Warehouse intelligence for ALVO.

Veridion Score
46
0: 611: 462: 503: 104: 735: 90
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ALVO insider activity

Alvotech Ordinary Shares

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ALVO.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ALVO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALVO in this window.
Lobbying spend

ALVO lobbying filings, year to date.

Registered lobbying filings matched to Alvotech Ordinary Shares.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALVO in this window.
Latest news · ALVO
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ALVO.
Options
Sovereign unlock shows live options positioning for ALVO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.